These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Extraintestinal considerations in inflammatory bowel disease. Levine JB; Lukawski-Trubish D Gastroenterol Clin North Am; 1995 Sep; 24(3):633-46. PubMed ID: 8809240 [TBL] [Abstract][Full Text] [Related]
24. Thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance. Di Fabio F; Lykoudis P; Gordon PH Semin Thromb Hemost; 2011 Apr; 37(3):220-5. PubMed ID: 21455856 [TBL] [Abstract][Full Text] [Related]
25. Septic thrombophlebitis of the superior mesenteric vein and multiple liver abscesses in a patient with Crohn's disease at onset. Aguas M; Bastida G; Nos P; Beltrán B; Grueso JL; Grueso J BMC Gastroenterol; 2007 Jun; 7():22. PubMed ID: 17565671 [TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662 [TBL] [Abstract][Full Text] [Related]
31. [Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease]. Stawarski A; Iwańczak B; Krzesiek E; Iwańczak F Pol Merkur Lekarski; 2006 Jan; 20(115):22-5. PubMed ID: 16617729 [TBL] [Abstract][Full Text] [Related]
32. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study]. Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638 [TBL] [Abstract][Full Text] [Related]
34. [Splenic granulomas - rare extraintestinal manifestation of Crohn's disease]. Schulz C; von Arnim U; Kuester D; Fischbach F; Malfertheiner P Z Gastroenterol; 2010 Dec; 48(12):1367-70. PubMed ID: 21125512 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery. Bucci C; Geerts WH; Sinclair A; Fremes SE Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996 [TBL] [Abstract][Full Text] [Related]
36. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism. Creekmore FM; Oderda GM; Pendleton RC; Brixner DI Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654 [TBL] [Abstract][Full Text] [Related]
38. [Retinal vasculitis in Crohn's disease: a case report]. Trojet S; Mazlout H; Hamdouni M; Toumi A; Jebali F; Cheour M; El Afrit MA; Kraiem A J Fr Ophtalmol; 2010 Jan; 33(1):54.e1-5. PubMed ID: 20022662 [TBL] [Abstract][Full Text] [Related]
39. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism. Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651 [TBL] [Abstract][Full Text] [Related]
40. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin. Harenberg J; Huisman MV; Tolle AR; Breddin HK; Kirchmaier CM Semin Thromb Hemost; 2001 Oct; 27(5):513-8. PubMed ID: 11668421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]